Heron Therapeutics says chief development officer Forbes buys 50K shares in co
Nov. 20, 2023 11:35 AM ETHeron Therapeutics, Inc. (HRTX)By: Sinchita Mitra, SA News Editor
- Heron Therapeutics (NASDAQ:HRTX) disclosed that its chief development officer William Forbes bought 50K shares in the company at $0.94 apiece on Nov. 16.
- Forbes now directly holds 54K shares in the company.
- In the last three months, net purchase activity was 233.4K shares through insider trading, with two buys and two sales.
- Shares in the company, up 18.81%.
